SHEILA KEMPER: Open Payments
NPI 1811252638 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 9 payments from 5 companies in 2025. Trend: 2023 $82 · 2024 $202 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $117 |
| JAZZ PHARMACEUTICALS INC. | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: Briviact, Fintepla, EPIDIOLEX, COBENFY, FANAPT, INGREZZA.
Industry payments across KY — which companies pay providers there.
